Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Executive Summary

Canaan raised $800m for tech and health care investments. Also, six companies closed VC rounds, CARB-X backed more antibiotics, CIRM funded BrainStorm and Sarepta led recent offerings.


Related Content

Iterum Therapeutics Focused On First Oral Penem
Accelerating Antibiotics: Kevin Outterson And Joe Larsen Explain CARB-X
With Serial Entrepreneur At Its Helm, Arrakis Raises $38m To Target RNA With Small Molecules
Ask A Digital Health Investor: Canaan’s Kjellson On Smart Strategies
Homology Medicines Inc.
Biotech VC Funding Rises As Fewer Companies Get More Dollars
Venture Funding Deals, July 2015
BioNotebook: Trevi, Complexa raise VC cash; Deerfield commits $60m to KemPharm; Aradigm, Voyager deal news; IPO updates
Milestone Pharmaceuticals Inc.
Emergings In Brief (11/2010)


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts